Navigation Links
Coalition for Pulmonary Fibrosis Fundraising Events Raise $280,000 for IPF
Date:10/29/2007

Events held in Chicago and Los Angeles provide foundation for new education

and research efforts to fight IPF

SAN JOSE, Calif., Oct. 29 /PRNewswire/ -- The Coalition for Pulmonary Fibrosis (CPF) is pleased to announce that two major fundraising events hosted in Chicago and Los Angeles have generated more than $280,000 in new funds to help those suffering from idiopathic pulmonary fibrosis (IPF), a rare and deadly lung disease which affects more than 128,000 people in the U.S. The La Nuit de la Papillion (Night of the Butterfly) was held in the Old Town area of Chicago on Sept. 19, and the Butterfly Garden Party was hosted in a private residence in Malibu, Calif. on Sept. 30.

Both events were hosted by members of the Roney family, whose dedication to the cause has provided generous annual support for the CPF's important work in the IPF community. This year their events raised more than $280,000, and the family's efforts since 2003 continue to provide much-needed funding for the CPF's work with IPF patients and researchers.

"The success of these spectacular events speaks volumes for the commitment and compassion of our supporters to help those affected by this terrible disease," said Mark Shreve, chief executive officer of the CPF. "We are grateful to all of our supporters, and we are overwhelmed by the generosity of everyone involved. Their dedication reinforces the CPF's firm commitment to find treatments and ultimately a cure for IPF."

The funds will be used to further the education, awareness, and research efforts of the CPF, as it seeks answers to a disease that takes 40,000 lives every year and remains one of the few untreatable diseases affecting such a large population.

More than 150 guests at the Chicago event enjoyed the Bistro Margot restaurant with French cuisine as well as a silent auction that featured a trip for two to Paris, France and an Oxygen Lepton Electric Scooter. In Los Angeles, more than
'/>"/>

SOURCE Coalition for Pulmonary Fibrosis
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. PRIMARY PULMONARY HYPERTENSION GENE DISCOVERED
2. Long travel increase pulmonary embolism
3. FDA Approves Remodulin for Pulmonary Hypertension
4. Antipsychotic Drug Linked to Pulmonary Embolism
5. Treating Pulmonary Arterial Hypertension In Children With Viagra
6. Pulmonary rehabilitation program effective for chronic obstructive pulmonary disease
7. CT Pulmonary Angiography Scan More Effective In Detecting Dangerous Blood Clots In The Legs
8. People Suffering From Chronic Pulmonary Disease To Get Relief From Harmonica
9. Risk Factors Can Identify Pulmonary Embolism
10. Hormone Can Foretell Presence Of Potentially Fatal Pulmonary Hypertension
11. Malfunction Of Key Growth Factor Increases Mortality Rate From Pulmonary Fibrosis In Blacks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2008)...mmune response after antiretroviral therapy may be... 25 (HealthDay News) -- A new study challenges the... impairs the immune system,s ability to restore it...tive antiretroviral therapy (HAART). , From 50 ...re also infected with HCV. Intravenous drug use is...
(Date:7/25/2008)..., July 25 /PRNewswire/ -- BeaconEquity.com announc...ng news today., Investors can view all of the dai...conEquity.com/m , Today,s Trade Alerts include: D...rook Pharmaceuticals Inc. (Nasdaq: MBRK ), NovaMe... ), Affymetrix Inc. (Nasdaq: AFFX ) and,Abaxis In...
(Date:7/25/2008)...Relationship Based on Significant Improvements in ... MDdatacor, Inc., a leader in health,care quality ...s, today,announced it has entered into a long-term...ort Wellmark,s Collaboration on Quality(SM) Incent...tion between Wellmark and,primary care clinicians ...
(Date:7/25/2008)...AD, Calif., July 25 /PRNewswire/ -- AutoGenomics, ...ion statement on Form S-1 with the,Securities and ...al public,offering of shares of its common stock. ..., all of which are expected to be offered by,AutoG...g, have not yet been,determined., J.P. Morgan Sec...
Breaking Medicine News(10 mins):Health News:Study Disproves Belief That Hepatitis C Blunts HIV Drugs 2Health News:BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX 2Health News:BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX 3Health News:MDdatacor Extends Contract with Wellmark, Inc. 2Health News:MDdatacor Extends Contract with Wellmark, Inc. 3Health News:AutoGenomics, Inc. Files Registration Statement for Initial Public Offering 2
...ios Spanos was shocked when his doctor discovered ... his body’s largest blood vessel, the aorta, durin...o symptoms, and was relieved to find out that the ...had been caught while it was still small. For the...
... A brewery in Japan launched production of unusual...farmer who was looking for ways to put his milk su...k will be available in the store shelves Thursday,...akashibetsu, on the country's northernmost island ...
... are planning to whiten your teeth by bleaching th...it done by unqualified people could cause consider...alons are offering teeth whitening by unqualified ...l bleach," said Christopher Orr, president of the ...
...tors and nurses who work in the developing world w...challenges, according to ‘Meeting the Health needs... The BMA’s International Committee surveyed 79 UK...including 67 doctors, who had recently worked in A...
Other Medicine News:Health News:Early Detection of Artery Weakening Can Be a Life-Saver 2Health News:Early Detection of Artery Weakening Can Be a Life-Saver 3Health News:Health Workers Need Better Preparation for Developing World 2
(Date:7/23/2008)...publication in July print edition of Clinical ...IANAPOLIS, July 23 /- A Roche Diagnos...-terminal pro-B-type natriuretic peptide,(NT-proBN...isk,stratification in predicting the risk of cardi...ed with non-steroidal anti-inflammatory drugs of,t...
(Date:7/23/2008)...Areas of the Body Have Greater Concentrations of,S...wswire-USNewswire/ -- Fat removed,from the lower a...nd to be,an excellent source of stem cells, with h... the body, reports a Brazilian-based study in Augu...ficial medical journal of the,American Society of ...
(Date:7/22/2008)...uly 22 /- Following a,thoro...d of Progen,Pharmaceuticals Limited (ASX: PGL; Nas...d the PI-88 phase 3 study in liver cancer. Progen ...xisting portfolio of compounds and,the company wil...d,opportunities through Merger & Acquisition activ...
(Date:7/22/2008)...uss Development Plan Completed Successfully, DUBL...rin Corporation,plc (NASDAQ: AMRN ) today announc... the U.S. Food and Drug Administration (FDA) to di...e treatment of,hypertriglyceridemia. Following the... 3 with AMR101 in hypertriglyceridemia., Dr. Decl...
Breaking Medicine Technology:Study Reveals Potential for NT-proBNP as a Marker to Predict Cardiovascular Risks From Anti-Inflammatory Drugs 2Study Reveals Potential for NT-proBNP as a Marker to Predict Cardiovascular Risks From Anti-Inflammatory Drugs 3Study Reveals Potential for NT-proBNP as a Marker to Predict Cardiovascular Risks From Anti-Inflammatory Drugs 4Want a Reason to Love Your Lower Belly Fat? It's Rich in Stem Cells 2Progen Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A 2Progen Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A 3Amarin Proceeding to Phase 3 With AMR101 for Hypertriglyceridemia 2Amarin Proceeding to Phase 3 With AMR101 for Hypertriglyceridemia 3Whole Foods Market 28R 29 Announces Eco Conscious Youth Hosts for Whole Earth Generation 28TM 29 Show 15624 1Whole Foods Market 28R 29 Announces Eco Conscious Youth Hosts for Whole Earth Generation 28TM 29 Show 15624 2Whole Foods Market 28R 29 Announces Eco Conscious Youth Hosts for Whole Earth Generation 28TM 29 Show 15624 3Whole Foods Market 28R 29 Announces Eco Conscious Youth Hosts for Whole Earth Generation 28TM 29 Show 15624 4Crannose 28TM 29 Extra Strength Womens Health Formula Targets Urinary Tract Infections 15620 1Crannose 28TM 29 Extra Strength Womens Health Formula Targets Urinary Tract Infections 15620 2Tengion Announces European Orphan Drug Designation for Neo Bladder Augment 4328 1Tengion Announces European Orphan Drug Designation for Neo Bladder Augment 4328 2China Bio Energy Reports Fiscal 2007 Financial Results 4324 1China Bio Energy Reports Fiscal 2007 Financial Results 4324 2China Bio Energy Reports Fiscal 2007 Financial Results 4324 3China Bio Energy Reports Fiscal 2007 Financial Results 4324 4China Bio Energy Reports Fiscal 2007 Financial Results 4324 5China Bio Energy Reports Fiscal 2007 Financial Results 4324 6China Bio Energy Reports Fiscal 2007 Financial Results 4324 7China Bio Energy Reports Fiscal 2007 Financial Results 4324 8China Bio Energy Reports Fiscal 2007 Financial Results 4324 9China Bio Energy Reports Fiscal 2007 Financial Results 4324 10China Bio Energy Reports Fiscal 2007 Financial Results 4324 11
...s Efficacy at Improving Glycemic Control and,Reduc..., Ill., June 23, 2007 /PRNewswire/ -- VeroScience,...rtner S2 Therapeutics,Inc., reported today the re...the overall and cardiovascular safety of Cycloset(...mesylate) in subjects,with type 2 diabetes. The st...
...--Jun 25, 2007 - HepaLife Technologies, Inc.,(OTCB...that new,data presented at an international influe...,s patented PBS-1 cell line outperforms,current ce...us,inside its cells. The most important step towar...against a targeted virus is the,ability to efficie...
Other Medicine Technology:Phase IIIb Clinical Data Validate the Overall and Cardiovascular,Safety Profile of Cycloset (A Quick Release Formulation of,Bromocriptine Mesylate) in Patients with Type 2 Diabetes 2Phase IIIb Clinical Data Validate the Overall and Cardiovascular,Safety Profile of Cycloset (A Quick Release Formulation of,Bromocriptine Mesylate) in Patients with Type 2 Diabetes 3Phase IIIb Clinical Data Validate the Overall and Cardiovascular,Safety Profile of Cycloset (A Quick Release Formulation of,Bromocriptine Mesylate) in Patients with Type 2 Diabetes 4Phase IIIb Clinical Data Validate the Overall and Cardiovascular,Safety Profile of Cycloset (A Quick Release Formulation of,Bromocriptine Mesylate) in Patients with Type 2 Diabetes 5HepaLife's PBS-1 Cells for Influenza Vaccine Production Prove,Superior at International Conference 2HepaLife's PBS-1 Cells for Influenza Vaccine Production Prove,Superior at International Conference 3HepaLife's PBS-1 Cells for Influenza Vaccine Production Prove,Superior at International Conference 4HepaLife's PBS-1 Cells for Influenza Vaccine Production Prove,Superior at International Conference 5HepaLife's PBS-1 Cells for Influenza Vaccine Production Prove,Superior at International Conference 6
...y Biotech Captia™ Varicella- Zoster Virus (VZV...s intended for the detection and quantitative dete...dividual serum specimens may be used for the deter...convalescent, may be used to demonstrate seroconve...
The DSL-05-10-VZM Varicella Zoster IgM Enzyme-Linked Immunosorbent Assay (ELISA) kit provides materials for the determination of IgM-class antibodies to Varicella Zoster Virus in human serum. This as
The Trinity Biotech Mumps IgM Enzyme-Linked Immunosorbent Assay (ELISA) is intended for the qualitative detection of IgM antibody in human serum to Mumps for the determination of immunological experi
The DIAGNOSTIC AUTOMATION, INC. (DAI) Mumps IgG Enzyme-Linked Immunosorbent Assay (ELISA) is intended for the detection and quantitative determination of IgG antibody to Mumps virus in human sera. In
Medicine Products: